Prostate-specific antigen (PSA) is an androgen-regulated serine protease produced by both
prostate epithelial cells and prostate cancer (PCa) and is the most commonly used serum …

This review outlines current international patterns in prostate cancer incidence and mortality
rates and survival, including recent trends and a discussion of the possible impact of …

Background Screening for prostate cancer using prostate-specific antigen (PSA) alone leads
to un-necessary biopsying and overdiagnosis. PSA density is easily accessible, but early …

Prostate cancer (CaP) is the leading cancer among men of African descent in the USA,
Caribbean, and Sub‐Saharan Africa (SSA). The estimated number of CaP deaths in SSA …

CONTEXT: Prostate cancer (PCa) screening to detect early stage PCa has resulted in
increased identification of small-volume, low-grade PCa, many of which meet criteria for …

The purpose of this study was to assess the predictive value of prostate specific antigen
density (PSAD) for detection of clinically significant prostate cancer in men undergoing …

In this study, an ultra-sensitive electrochemical immunosensor for PSA detection was
designed. Firstly, gold nanoparticles (AuNPs)/p-aminothiophenol (ATP) functionalized …

The aim of this work was to investigate volatile organic compounds (VOCs) emanating from
urine samples to determine whether they can be used to classify samples into those from …

Background: In US men, prostate cancer is the most common noncutaneous cancer and the
second leading cause of cancer death. Screening for prostate cancer is controversial …

The introduction of total prostate specific antigen (total PSA) testing in blood has
revolutionized the detection and management of men with prostate cancer (PCa). The …